LSD Therapy Shows Promise in Anxiety Trial
- Published:
- First detected:
Insights by Echo AI
Definium Therapeutics announced that its LSD-based therapy significantly reduced anxiety symptoms in patients with generalized anxiety disorder (GAD) in the first of two large-scale trials. The benefits were observed as early as two days after dosing and lasted throughout the 12-week study. This is the second major victory for Definium this year with its proprietary version of LSD.
Source coverage
5
records merged
3
3 unique
0
0 unique
2
2 unique
5 Sources
Definium Therapeutics said that its LSD therapy significantly helped p...
Definium Therapeutics says its LSD therapy eased anxiety in late-stage...
LSD Just Passed Its Biggest Trial Yet for Anxiety It's the second majo...
Definium says LSD-based pill reduces anxiety in late-stage study The ...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
